MedPath

the effect of zolpidem and lorazepam on the severity

Not Applicable
Conditions
F40, F41,
severe insomnia.
Neurotic, stress-related and somatoform disorders
Registration Number
IRCT2015081021309N2
Lead Sponsor
Deputy of Research and Technology, Golestan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

All addict patients treated with methadone and with severe insomnia
Exclusion criteria: Medical and psychiatric illness that causes sleep disorders are serious. Use other hypnotic drugs before or during the study. Change the dose of methadone

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Insomnia. Timepoint: at the begining of study. Method of measurement: ISI Insomnia Questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath